Drug information for HUMULIN 50/50
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
50 UNITS/ML;50 UNITS/ML
Discontinued
INSULIN RECOMBINANT HUMAN
;
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
Insulin, Isophane
LILLY
20100
2007-09-11 Letter
2007-08-27 Letter
2007-08-23 Label
2003-11-25 Letter
Drug Adverse Effects information for HUMULIN 50/50
Role code
Indications
Reaction
# Reports
SS
TYPE 2 DIABETES MELLITUS
BLOOD GLUCOSE INCREASED
2
SS
TYPE 2 DIABETES MELLITUS
CEREBROVASCULAR ACCIDENT
2
SS
TYPE 2 DIABETES MELLITUS
DYSGRAPHIA
2
SS
TYPE 2 DIABETES MELLITUS
DYSSTASIA
2
SS
TYPE 2 DIABETES MELLITUS
EYE DISORDER
2
SS
TYPE 2 DIABETES MELLITUS
HYPOACUSIS
2
SS
TYPE 2 DIABETES MELLITUS
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
2
SS
TYPE 2 DIABETES MELLITUS
MEMORY IMPAIRMENT
2
SS
TYPE 2 DIABETES MELLITUS
SPEECH DISORDER
2
SS
TYPE 2 DIABETES MELLITUS
VISUAL ACUITY REDUCED
2
SS
TYPE 2 DIABETES MELLITUS
WALKING DISABILITY
2
Ads by Google